These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38677730)

  • 1. Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation.
    Samukawa Y; Ouchi Y; Miyashita T; Rahman A; Tsukamoto I; Yoshihara A; Hoshikawa H
    Anticancer Res; 2024 May; 44(5):1895-1903. PubMed ID: 38677730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effects of D-allose: up-regulation of thioredoxin-interacting protein in head and neck cancer cells.
    Hoshikawa H; Mori T; Mori N
    Ann Otol Rhinol Laryngol; 2010 Aug; 119(8):567-71. PubMed ID: 20860283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the radiation effects by D-allose in head and neck cancer cells.
    Hoshikawa H; Indo K; Mori T; Mori N
    Cancer Lett; 2011 Jul; 306(1):60-6. PubMed ID: 21439723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression.
    Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F
    Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with D-allose, docetaxel and radiation inhibits the tumor growth in an
    Hoshikawa H; Kamitori K; Indo K; Mori T; Kamata M; Takahashi T; Tokuda M
    Oncol Lett; 2018 Mar; 15(3):3422-3428. PubMed ID: 29456721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
    Tohi Y; Taoka R; Zhang X; Matsuoka Y; Yoshihara A; Ibuki E; Haba R; Akimitsu K; Izumori K; Kakehi Y; Sugimoto M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of head and neck carcinomas by D-allose.
    Mitani T; Hoshikawa H; Mori T; Hosokawa T; Tsukamoto I; Yamaguchi F; Kamitori K; Tokuda M; Mori N
    Head Neck; 2009 Aug; 31(8):1049-55. PubMed ID: 19340872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D-allose in combination with docetaxel in human head and neck cancer cells.
    Indo K; Hoshikawa H; Kamitori K; Yamaguchi F; Mori T; Tokuda M; Mori N
    Int J Oncol; 2014 Nov; 45(5):2044-50. PubMed ID: 25109398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare sugar D-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells.
    Yamada K; Noguchi C; Kamitori K; Dong Y; Hirata Y; Hossain MA; Tsukamoto I; Tokuda M; Yamaguchi F
    Nutr Res; 2012 Feb; 32(2):116-23. PubMed ID: 22348460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1.
    Yamaguchi F; Takata M; Kamitori K; Nonaka M; Dong Y; Sui L; Tokuda M
    Int J Oncol; 2008 Feb; 32(2):377-85. PubMed ID: 18202760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.
    Malm SW; Hanke NT; Gill A; Carbajal L; Baker AF
    J Exp Clin Cancer Res; 2015 Apr; 34(1):31. PubMed ID: 25888489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
    Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
    Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-allose: Molecular Pathways and Therapeutic Capacity in Cancer.
    Khajeh S; Ganjavi M; Panahi G; Zare M; Zare M; Tahami SM; Razban V
    Curr Mol Pharmacol; 2023; 16(8):801-810. PubMed ID: 36578261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.
    Yamaguchi F; Kamitori K; Sanada K; Horii M; Dong Y; Sui L; Tokuda M
    J Biosci Bioeng; 2008 Sep; 106(3):248-52. PubMed ID: 18930000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effects of D-allose associated with reduced cell division frequency in glioblastoma.
    Suzuki K; Ogawa D; Kanda T; Fujimori T; Shibayama Y; Rahman A; Ye J; Ohsaki H; Akimitsu K; Izumori K; Tamiya T; Nishiyama A; Miyake K
    Sci Rep; 2023 Nov; 13(1):19515. PubMed ID: 37945736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the inhibitory mechanism of D-allose on MOLT-4F leukemia cell proliferation.
    Hirata Y; Saito M; Tsukamoto I; Yamaguchi F; Sui L; Kamitori K; Dong Y; Uehara E; Konishi R; Janjua N; Tokuda M
    J Biosci Bioeng; 2009 May; 107(5):562-8. PubMed ID: 19393559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
    Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
    Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
    Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a d-allose-6-phosphate derivative with anti-proliferative activity against a human leukemia MOLT-4F cell line.
    Ishiyama H; Yanagita RC; Takemoto K; Kobashi K; Sugiyama Y; Kawanami Y
    Carbohydr Res; 2020 Jan; 487():107859. PubMed ID: 31751780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab.
    Li X; Lu Y; Lu H; Luo J; Hong Y; Fan Z
    Oncotarget; 2015 May; 6(13):11507-18. PubMed ID: 25871473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.